Trials / Withdrawn
WithdrawnNCT04230564
Acute Myeloid Leukemia Real World Treatment Patterns
Characteristics, Treatment Patterns, and Clinical Outcomes in Non-intensive Chemotherapy Acute Myeloid Leukemia (AML) Patients - a US Real-World Study Using Electronic Medical Record Data
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Among patients with a diagnosis of AML who received non-intensive chemotherapy: * Describe patient demographic and clinical characteristics * Describe treatment patterns * Describe effectiveness outcomes * Evaluate tumor response
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | azacitidine | Patients taking azacitidine |
| DRUG | venetoclax | patients taking venetoclax |
| DRUG | glasdegib | patients taking glasdegib |
Timeline
- Start date
- 2020-10-31
- Primary completion
- 2021-03-31
- Completion
- 2021-03-31
- First posted
- 2020-01-18
- Last updated
- 2023-06-07
Source: ClinicalTrials.gov record NCT04230564. Inclusion in this directory is not an endorsement.